Hay – författare
Visar alla böcker från författaren Hay. Handla med fri frakt och snabb leverans.
4 produkter
4 produkter
477 kr
Skickas inom 5-8 vardagar
In this sparkling collection of anecdotes about the stars before and behind the cameras, Peter Hay takes the reader on a delightful - if occasionally bumpy - ride through the world that has captivated audiences for almost a century. Moguls' heads would spin if they reckoned the fees for a cast that includes Chaplin, Garbo, Gable, Bogart, Davis, Crawford, Monroe, Nicholson, Streep, and assorted Hepburns, Fondas, and Hustons, but here they all are, and under the keen directorial eyes of Griffith, Eisenstein, Hitchcock, Kurosawa, Bergman, Welles, Ford, and Visconti, to name but a few. If you think the credits are good wait until you get a look at the plot, which bursts at the seams with battles over money, contracts, and artistic control, overnight sensations, tragic declines, romances, divorces, and any number of scandals. For anyone who has spent a night at the movies, this colourful, incredible, bitter, and hilarious book is a must.
371 kr
Skickas inom 5-8 vardagar
311 kr
Skickas inom 5-8 vardagar
556 kr
Skickas inom 10-15 vardagar
The biology of the family of endogenous autocrine peptides known as the endothelins (ETs) has been a source of intense study for researchers since 1988, following the identification of ET-l as the previously described endothelium-derived contractile factor. Initial interest focussed on the actions of the ETs in the cardiovascular system, and this remains the pri mary source of published work involving these peptides. Importantly, evi dence is mounting for a significant mediator role for ET-l in cardiovascu lar diseases including systemic hypertension and congestive heart failure. However, it was also recognized early on that the ETs exert an array of powerful actions in the respiratory tract, many of which prompted specula tion concerning mediator roles for ET-l in several lung diseases including asthma and pulmonary hypertension. In recent years the evidence for the involvement of ET-l in lung diseases has become more compelling. There is now real hope and anticipation that novel ET receptor antagonists may eventually be used therapeutically against asthma and other major lung pathologies. It is this atmosphere of excitement created by new discoveries and the increasing scientific ratio nale for a significant impact ofthe ETs in pulmonary diseases that prompt ed the creation of this book, the first on this topic. Most of the information presented relates to ET-l, which is the most widely studied member of the ET family.